Reply by Authors

Affiliations

¹ Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
² Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida.
³ Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
⁵ Urologic Oncology (Surgery), Wayne B. Duddlesten Professor of Cancer Research, University of Texas MD Anderson Cancer Center, Houston, Texas.

Comment

Justin T Matulay et al. J Urol. 2021 Jun.

. 2021 Jun;205(6):1620-1621.

doi: 10.1097/JU.0000000000001633.03. Epub 2021 Mar 18.

¹ Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
² Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida.
³ Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
⁵ Urologic Oncology (Surgery), Wayne B. Duddlesten Professor of Cancer Research, University of Texas MD Anderson Cancer Center, Houston, Texas.

No abstract available

Comment on

Editorial Comment.
Matulewicz RS, Steinberg GD. Matulewicz RS, et al. J Urol. 2021 Jun;205(6):1619-1620. doi: 10.1097/JU.0000000000001633.01. Epub 2021 Mar 18. J Urol. 2021. PMID: 33734860 No abstract available.
Editorial Comment.
Woldu SL. Woldu SL. J Urol. 2021 Jun;205(6):1620. doi: 10.1097/JU.0000000000001633.02. Epub 2021 Mar 18. J Urol. 2021. PMID: 33734861 No abstract available.